Trump’s ‘Obamacare Lite’ presents opportunities and perils for investors By: MarketWatch March 08, 2017 at 05:13 AM EST Health-care insurers and medical-device companies would benefit. Also, expect a wave of M&A, writes Nigam Arora. Read More >> Related Stocks: Aetna Alexion Pharmaceuticals Anthem Inc Biomarin Pharmaceuticals Boston Scientific Bristol-Myers Squibb Centene Corp Cigna Corp Community Health Systems Dow Industrials SPDR Edwards Lifesciences Eli Lilly HEALTHCARE Hca Holdings Inc Humana Jazz Pharma Plc Johnson & Johnson Medtronic Merck & Co Molina Healthcare Inc Mylan Pfizer Puma Biotechnology S&P Biotech SPDR S&P Healthcare Services SPDR Stryker Corp Tenet Healthcare Teva Pharmaceutical Industries ADR US Medical Devices Ishares ETF UnitedHealth Group Vanda Pharmaceuticals Wellcare Group Zimmer Holdings